Focus Meeting 5
MOLECULAR IMAGING AND THERANOSTICS
IN PROSTATE CANCER –
THE FUTURE BEGINS TODAY
February 2-4, 2023
Seville, Spain
Consensus Paper
We are delighted to announce that the consensus paper from the EANM Focus Meeting 5 entitled ‘European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer’ has been published in the European Urology.
This publication results from the collaborative effort of all the panellists who contributed their expertise and knowledge to the discussion.
Read here the Editorial article about the meeting and its outcomes published in the European Journal of Nuclear Medicine and Molecular Imaging.
We extend our gratitude to the EANM Focus Meeting 5 Expert Panel for its valuable input.
Scientific Programme
For a comprehensive overview of the EANM Focus Meeting 5, kindly click on the buttons below to access the scientific programme.
EANM Focus Meeting 5 Trailer
Sponsors
We express our sincere gratitude to the following companies for their sponsorship engagement:
Diamond Sponsor
 |
|
Advanced Accelerator Applications A Novartis Company |
Platinum Sponsor
 |
 |
| Monrol | Spectrum Dynamics Medical Ltd. |
Gold Sponsors
 |
 |
 |
 |
 |
| Blue Earth Diagnostics | GE HealthCare | ITM Isotope Technologies Munich SE | Siemens Healthineers | Telix Pharmaceuticals |